Visacor

Χώρα: Νέα Ζηλανδία

Γλώσσα: Αγγλικά

Πηγή: Medsafe (Medicines Safety Authority)

Δραστική ουσία:

Rosuvastatin calcium 10.4mg equivalent to 10 mg rosuvastatin

Διαθέσιμο από:

AstraZeneca Limited

INN (Διεθνής Όνομα):

Rosuvastatin calcium 10.4 mg (= 10 mg rosuvastatin)

Δοσολογία:

10 mg

Φαρμακοτεχνική μορφή:

Film coated tablet

Σύνθεση:

Active: Rosuvastatin calcium 10.4mg equivalent to 10 mg rosuvastatin Excipient: Calcium phosphate Crospovidone Hypromellose as Opadry Pink Iron oxide red as Opadry Pink Lactose monohydrate as Opadry Pink   Magnesium stearate Microcrystalline cellulose Titanium dioxide as Opadry Pink Triacetin as Opadry Pink

Μονάδες σε πακέτο:

Blister pack, Al/Al foil, 7 tablets

Kατηγορία:

Prescription

Τρόπος διάθεσης:

Prescription

Κατασκευάζεται από:

IPR Pharmaceuticals Inc

Θεραπευτικές ενδείξεις:

VISACOR is indicated to: - Reduce elevated LDL-C, Total Cholesterol, triglycerides and to increase HDLcholesterol in patients with primary hypercholesterolemia (heterozygous familial and non familial) and mixed dyslipidaemia (Fredrickson Types IIa and IIb). - Treat isolated hypertriglyceridaemia (Fredrickson Type IV hyperlipidaemia). Reduce Total Cholesterol and LDL-C in patients with homozygous familial hypercholesterolemia, as an adjunct to diet and other lipid lowering treatments (eg. LDL apheresis) or alone if such treatments are unavailable.

Περίληψη προϊόντος:

Package - Contents - Shelf Life: Blister pack, Al/Al foil - 7 tablets - 36 months from date of manufacture stored at or below 30°C - Blister pack, Al/Al foil - 30 tablets - 36 months from date of manufacture stored at or below 30°C

Ημερομηνία της άδειας:

2009-07-31